Literature DB >> 1954081

Pharmacokinetics of halofantrine in healthy Thai volunteers.

J Karbwang, S A Ward, K A Milton, K Na Bangchang, G Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1954081      PMCID： PMC1368647          DOI： 10.1111/j.1365-2125.1991.tb03968.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Introduction of halofantrine for malaria treatment.

Authors:  R J Horton
Journal:  Parasitol Today       Date:  1988-09

2.  Pharmacokinetics of halofantrine in man: effects of food and dose size.

Authors:  K A Milton; G Edwards; S A Ward; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

3.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

4.  Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.

Authors:  J Karbwang; K A Milton; K Na Bangchang; S A Ward; G Edwards; D Bunnag
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

5.  Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand.

Authors:  E F Boudreau; L W Pang; K E Dixon; H K Webster; K Pavanand; L Tosingha; P Somutsakorn; C J Canfield
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408
  5 in total
  4 in total

1.  Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Authors:  D R Abernethy; D L Wesche; J T Barbey; C Ohrt; S Mohanty; J C Pezzullo; B G Schuster
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

2.  Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.

Authors:  G Fadat; F J Louis; J P Louis; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients.

Authors:  F Gimenez; C Gillotin; L K Basco; O Bouchaud; A F Aubry; I W Wainer; J Le Bras; R Farinotti
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.